Optra HFA®

Optra HFA®

Therapeutic Segment: Anti-Asthmatic

Generic Name: Ipratropium bromide monohydrate

Indication:

For:

  • Bronchodilator for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
  • Adjunct to beta2-agonists in the management of acute severe asthma.

Available as:

Metered Dose Inhaler
  • 20mcg